TX360®

A minimally invasive applicator for primary and induced headaches.
Contact us

Last updated on November 28, 2023

TX360®

The TX360® – developed by Tian Médical, is a drug delivery system representing a breakthrough in medical technology, offering key advantages for sphenopalatine ganglion blockade. This minimally invasive system enables fast, easy administration, ensuring rapid relief for patients suffering from a variety of cephalalgic conditions. The device’s unique features make it one of the few of its kind in the world, transforming drug delivery.

Symptomes pris en charge :

  • Primary headaches
  • Migraines with or without aura
  • Tension headaches
  • Post-traumatic stress headache
  • Atypical facial pain
  • Trigeminal neuralgia

Headaches, characterized by recurrent headaches, are one of the most widespread disorders of the nervous system. It is generally estimated that almost half the adult population has had at least one headache in the past year. Headaches are associated with a burden on the individual and society, in the form of pain, disability and deterioration in quality of life. Headache is the painful, incapacitating manifestation of a limited number of primary headache disorders, namely migraine, tension headache and facial vascular angina.

TX360® - Global architecture

The TX360® nasal applicator, a single-use device, is specially designed to inject small quantities of medication to target the ganglion in the sphenopalatine foramen. Clinically proven efficacy and the absence of side effects make this system a reliable choice for treating a variety of indications, including migraine with or without aura, primary headache, tension-type headache, post-traumatic stress headache, atypical facial pain and trigeminal neuralgia.

The device’s mechanism of action and treatment protocol involve both acute and prophylactic approaches. Acutely, the system is administered once bilaterally for immediate relief. Prophylactically, an initial neuromodulation treatment comprising 12 sessions over 3 to 6 weeks is followed by a maintenance treatment every 3 to 6 months. These treatments aim to restore normal physiological function in the cranial region, thereby relieving head and facial pain.

The TX360® drug delivery system is positioned as an innovative solution in the field of headache treatment, offering a unique and effective approach to treating a variety of conditions